Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 871

1.

Hypersensitivity Reactions, Immediate.

Justiz Vaillant AA, Zito PM.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Jul 16.

2.

Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9.

Salloum N, Hussein HM, Jammaz R, Jiche S, Uthman IW, Abdelnoor AM, Rahal EA.

PLoS One. 2018 Jul 11;13(7):e0200546. doi: 10.1371/journal.pone.0200546. eCollection 2018.

3.

Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings.

Gong S, Crane GM, McCall CM, Xiao W, Ganapathi KA, Cuka N, Davies-Hill T, Xi L, Raffeld M, Pittaluga S, Duffield AS, Jaffe ES.

Am J Surg Pathol. 2018 Jun 27. doi: 10.1097/PAS.0000000000001113. [Epub ahead of print]

PMID:
29957733
4.

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features.

Namiki T, Sone Y, Miura K, Tanaka M, Yokozeki H.

Case Rep Dermatol. 2018 May 29;10(2):149-153. doi: 10.1159/000489694. eCollection 2018 May-Aug.

5.

Role of Epstein-Barr virus infection in SLE: gene-environment interactions at the molecular level.

Pisetsky DS.

Ann Rheum Dis. 2018 Jun 1. pii: annrheumdis-2018-213783. doi: 10.1136/annrheumdis-2018-213783. [Epub ahead of print] No abstract available.

PMID:
29858172
6.

Hemophagocytic Lymphohistiocytosis Secondary to Unknown Underlying Hodgkin Lymphoma Presenting with a Cholestatic Pattern of Liver Injury.

Booth AL, Osehobo P, Rodgers-Soriano D, Lalarukh A, Eltorky MA, Stevenson HL.

Case Rep Gastroenterol. 2018 Apr 24;12(1):99-108. doi: 10.1159/000486190. eCollection 2018 Jan-Apr. Review.

7.

Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.

Sakumura N, Shimizu M, Mizuta M, Inoue N, Nakagishi Y, Yachie A.

Cytokine. 2018 May 23. pii: S1043-4666(18)30216-3. doi: 10.1016/j.cyto.2018.05.017. [Epub ahead of print]

PMID:
29801971
8.

Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.

Kraal LJN, Nijland ML, Germar KL, Baeten DLP, Ten Berge IJM, Fehres CM.

PLoS One. 2018 May 10;13(5):e0197219. doi: 10.1371/journal.pone.0197219. eCollection 2018.

9.

Genomic Profile and Pathologic Features of Diffuse Large B-Cell Lymphoma Subtype of Methotrexate-associated Lymphoproliferative Disorder in Rheumatoid Arthritis Patients.

Carreras J, Yukie Kikuti Y, Miyaoka M, Hiraiwa S, Tomita S, Ikoma H, Kondo Y, Shiraiwa S, Ando K, Sato S, Suzuki Y, Miura I, Roncador G, Nakamura N.

Am J Surg Pathol. 2018 Jul;42(7):936-950. doi: 10.1097/PAS.0000000000001071.

PMID:
29738359
10.

Methotrexate-associated Epstein-Barr virus mucocutaneous ulcer: A case report and review of literature.

Ravi PY, Sigamani E, Jeelani Y, Manipadam MT.

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):255-257. doi: 10.4103/IJPM.IJPM_135_16.

11.

Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity.

Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, Barski A, Salomonis N, Kaufman KM, Kottyan LC, Weirauch MT.

Nat Genet. 2018 May;50(5):699-707. doi: 10.1038/s41588-018-0102-3. Epub 2018 Apr 16.

PMID:
29662164
12.

Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis.

Kuusela E, Kouri VP, Olkkonen J, Koivuniemi R, Äyräväinen L, Rajamäki K, Valleala H, Nordström D, Leirisalo-Repo M, Ainola M, Eklund KK.

Clin Exp Rheumatol. 2018 Mar 20. [Epub ahead of print]

PMID:
29600942
13.

Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT.

Ward J, Noy A, Ulaner G, Riedl C.

Clin Nucl Med. 2018 May;43(5):344-345. doi: 10.1097/RLU.0000000000002054.

PMID:
29538028
14.

Iatrogenic T-Cell Lymphoma with Associated Hemophagocytic Lymphohistiocyotsis in a Patient with Long-Standing Rheumatoid Arthritis.

Andrade XA, Fuentes HE, Oramas DM, Mann H, Kovarik P.

Case Rep Hematol. 2018 Jan 11;2018:8097965. doi: 10.1155/2018/8097965. eCollection 2018.

15.

Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis.

Trier NH, Holm BE, Heiden J, Slot O, Locht H, Lindegaard H, Svendsen A, Nielsen CT, Jacobsen S, Theander E, Houen G.

Sci Rep. 2018 Feb 27;8(1):3684. doi: 10.1038/s41598-018-22058-6.

16.

Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.

Bonanni A, Calatroni M, D'Alessandro M, Signa S, Bertelli E, Cioni M, Di Marco E, Biassoni R, Caridi G, Ingrasciotta G, Bertelli R, Di Donato A, Bruschi M, Canepa A, Piaggio G, Ravani P, Ghiggeri GM.

Br J Clin Pharmacol. 2018 Jun;84(6):1238-1249. doi: 10.1111/bcp.13548. Epub 2018 Mar 25.

PMID:
29436729
17.

Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens.

Bo M, Niegowska M, Erre GL, Piras M, Longu MG, Manchia P, Manca M, Passiu G, Sechi LA.

Sci Rep. 2018 Jan 29;8(1):1789. doi: 10.1038/s41598-018-19957-z.

18.

Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis.

Trier N, Izarzugaza J, Chailyan A, Marcatili P, Houen G.

Int J Mol Sci. 2018 Jan 21;19(1). pii: E317. doi: 10.3390/ijms19010317. Review.

19.
20.

Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin Type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis.

Saburi M, Ogata M, Yoshida N, Nashimoto Y, Moroga Y, Takano K, Kohno K, Daa T, Shirao K.

Intern Med. 2018 Apr 15;57(8):1145-1149. doi: 10.2169/internalmedicine.9599-17. Epub 2017 Dec 27.

Supplemental Content

Loading ...
Support Center